Lv5
839 积分 2023-02-16 加入
Permeation enhancer-induced membrane defects assist the oral absorption of peptide drugs
9天前
已完结
Once-weekly semaglutide 7·2 mg in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b trial
14天前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
30天前
已完结
Once-monthly efimosfermin for non-cirrhotic MASH
30天前
已完结
Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity
1个月前
已完结
Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial
1个月前
已完结
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept
1个月前
已完结
Activin Actions in Adipocytes
2个月前
已完结
Myostatin: Basic biology to clinical application
2个月前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
2个月前
已完结
皖公网安备34019202002308
